Daniela Di Blasi

Daniela Di Blasi is a Clinical Scientist at Anaveon. Daniela has also worked as a Senior Biomedical Scientist at Scailyte AG and as a Clinical Research Scientist at Sanquin. Her work focuses on the execution of project development in oncology, immunology, and hematology, as well as leading and coordinating clinical projects with academic, clinical, and industrial partners. Daniela is also responsible for writing project proposals, grant applications, and patents.

Di Blasi has also worked on immune monitoring of autoreactive antigen-specific T and B cells and patients' response to therapy, including data analysis and interpretation in a GCP compliant work environment. Daniela has also been involved in writing clinical protocols, immunoassay development, and identification of new technologies for scientific strategy. In addition to their work in the lab, they have also taught and supervised lab members (PhD students and lab technicians).

Daniela Di Blasi holds a PhD in Immunology from Università degli Studi di Palermo, a Master's degree in Cellular and Molecular Biology from the same school, and a Bachelor's degree in Biology/Biological Sciences (with a focus on Molecular Biology) from Università degli Studi di Palermo.

They are on a team with Alexander Rau - Scientist, Protein Engineering, Pia Neubert - Associate Scientist, and Laetitia Petersen - Senior Scientist. Their manager is Christoph Huber, Chief Scientific Officer.